Canada · Venture startup

Who invested in AngioChem

3 rounds we have observed, with the 3 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Funding summaryUpdated 26 Oct 2026

$9.8Mraised across 3 rounds since 2005, from 3 sources

$807KVenture$6.0MVenture$3.0MVenture
Latest round
Venture, $3.0MDec 2007
Biggest round
$6.0MVenture · Dec 2005
Investors
3
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

200520062007
$807KVenture$6.0MVenture$3.0MVenture
First round
Venture, $807K
Jan 2005
Biggest round
$6.0M
Venture · Dec 2005
Usual gap between rounds
2 years
the median of 2

The rounds

  1. Dec 2007
    Venture$3.0M1 new

    From a historical funding record

  2. Dec 2005
    Venture$6.0M1 new1 returning

    Reported by angiochem.com

  3. Jan 2005
    Venture$807K1 new

    From a historical funding record

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

BDC CapitalVC firm2rounds

Missing a round, or an investor who was in one? Tell us.

Quick answers about AngioChem

Who invested in AngioChem?

AngioChem's investors include BDC Capital, MMV Capital Partners and VIMAC Milestone Medical Fund.

How much has AngioChem raised?

AngioChem has raised $9.8M across 3 rounds since 2005.

When did AngioChem last raise?

AngioChem's most recent round was a Venture of $3.0M in Dec 2007.

What was AngioChem's biggest round?

AngioChem's largest round on record is $6.0M (Venture), in Dec 2005.

Who backed AngioChem first?

AngioChem's first round on record, in Jan 2005, was backed by BDC Capital.

What stage is AngioChem at?

AngioChem's latest named round is a Venture, in Dec 2007.

Where is AngioChem based?

AngioChem is based in Canada.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.